Mr. Niemi has over 20 years’ experience in development, construction and design in hospitality, wellness, rehabilitation, senior residence centres and geriatric hospitals, through the Sunborn Group, Saga Palvelut Ltd and Ruissalo Foundation.
Mr. Niemi holds various director and board positions and is a major shareholder and director in Sunborn Group and Saga Palvelut Oy (Ltd), which together with the Ruissalo Foundation were the pioneers in developing the Finnish Assited Living model. The Foundations Saga Senior Centers with over 850 specialised Senior Assisted Living apartments are considered the benchmark for senior living in Finland.
Mr. Niemi is also the Chairman of the Malaysian-Finnish Business Council, holds a director position in the EU-Malaysia Chamber of Commerce and Industry and is the chairman of the EUMCCI Healthcare Committee.

Calvin possess a Degree in Computing with Computer Security as his major. He kick-started his career 8 years ago with F-Secure as a Malware Analyst. His main task were analysing and understanding malware behaviour to prevent them from manifesting further. He later moved on as a Security Vulnerability Expert within the company, focussing on vulnerability management. Calvin now manages the entire team of malware analysts and security experts. His passion is to raise cyber security awareness in a meaningful way.

Rod joined Siemens Healthineers Malaysia in 2016 following a distinguish career spanning three decades in the healthcare industry.
Prior to his current position, Rod served as the General Manager of Roche Diagnostics Malaysia and was instrumental for nurturing solid partnerships and driving business growth. He had a long and successful tenure with Roche Diagnostics in regional and international capacity, having served as the International Account Manager for Roche Diagnostics Asia Pacific, Singapore as well as the National Marketing Manager for Roche Diagnostics Australia.
Passionate, self-driven and result oriented, Rod brings forth a wealth of experience in addition to his firm background in diagnostics. He holds a Masters of Business Administration from the University of New South Wales and a Bachelor of Science from Macquarie University, Australia.

Azrul is a Partner at Wong Jin Nee & Teo and has over 17 years of experience dealing in intellectual property matters including developing and executing anti-counterfeiting and brand protection programmes for MNCs. He also deals with a wide range of litigation matters involving patent infringement, trade mark, copyright, trade secret, passing off, trade libel and unlawful interference with trade.
Azrul also provides advisory services for businesses in relation to compliance with trade rules, regulations and statutory issues.

Mrs. Koh is a past Director / Senior Regulatory Consultant in Medical Devices Branch & Compliance Branch in the Health Sciences Authority of Singapore for 8 years. Her professional career includes being co-Chair of the ASEAN Medical Device Working Group, (ACCSQ-MDPWG) (2008-2014) working on the AMDD up to its ministerial agreement in 2014; Chair in the Asian Harmonization Working Party Technical Committee (AHWP-TC) (2008-2014) & current Advisor to Post Market Workgroup.
Lastly, Mrs. Koh is a past Member of Singapore Council of Standards; International Medical Device Regulators Forum (IMDRF) UDI Workgroup; and Global Medical Device Nomenclature (GMDN) Policy Advisory Group.

Dr. David Teo is the Asia Region Lead in Telemedicine to support clients at remote locations, Offshore Oil and Gas and construction projects in Asia and Africa. Dr Teo oversees the assistance and medical services by heading expert teams of doctors and nurses in Assistance Centres to ensure a high level of service for clients in this region.

Woo San San is the Managing Director of Materialise in Malaysia. Materialise incorporates 27 years of 3D printing experience into a range of software solutions and 3D printing services, which together form the backbone of the 3D printing industry.
Materialise has pioneered many of the leading medical applications of 3D printing, enables researchers, engineers and clinicians to revolutionize innovative patient-specific treatment that helps improve and save lives. Materialise open and flexible platform of software and services, Materialise Mimics, forms the foundation of certified Medical 3D Printing, in clinical as well as research environments, offering virtual planning software tools, 3D-printed anatomical models, and patient-specific surgical guides and implants.